Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aduhelm Label Update Includes Seizure Risk And Recommends More MRIs
May 02 2022
•
By
Jessica Merrill
Aduhelm's prescribing information was updated by FDA • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Neurological
More from Therapeutic Category